【结 构 式】 |
【分子编号】30305 【品名】2-(4-nitrophenyl)acetic acid 【CA登记号】104-03-0 |
【 分 子 式 】C8H7NO4 【 分 子 量 】181.14792 【元素组成】C 53.04% H 3.89% N 7.73% O 35.33% |
合成路线1
该中间体在本合成路线中的序号:(I)The reaction of 4-nitrophenylacetic acid (I) with formaldehyde and dimethylamine in water gives 2-(4-nitrophenyl)-3-(dimethylamino)propionic acid (II), which by treatment with refluxing concentrated HCl is converted into 2-(4-nitrophenyl)acrylic acid (III). The esterification of (III) with methanol and p-toluenesulfonic acid yields the corresponding methyl ester (IV), which is reduced with H2 over Pd/C in ethanol to afford methyl 2-(4-aminophenyl)propionate (V). The alkylation of (V) with 2-methylallyl chloride (VI) by means of pyridine in refluxing ethanol gives methyl 2-[4-(2-methylallylamino)phenyl]propionate (VII), which is finally hydrolyzed with NaOH in refluxing methanol.
【1】 Dumaitre, B.; et al.; Synthesis of some analgesic and antiinflammatory 4-aminophenylacetic and 4-aminophenylacetic and 2-(4-aminophenyl)propionic acid derivatives. Eur J Med Chem - Chim Ther 1979, 14, 3, 207-214. |
【2】 Bouchara, E. (Laboratoires du Dr. E. Bouchara); Nouveau procede de preparation de derives de l'acide phenylacetique. FR 2289180 . |
【3】 Serradell, M.N.; Castaner, J.; Alminoprofen. Drugs Fut 1984, 9, 3, 165. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 30305 | 2-(4-nitrophenyl)acetic acid | 104-03-0 | C8H7NO4 | 详情 | 详情 |
(II) | 30306 | N,N-dimethyl-2-(4-nitrophenyl)-beta-alanine | C11H14N2O4 | 详情 | 详情 | |
(III) | 30307 | 2-(4-nitrophenyl)acrylic acid | C9H7NO4 | 详情 | 详情 | |
(IV) | 30308 | methyl 2-(4-nitrophenyl)acrylate | C10H9NO4 | 详情 | 详情 | |
(V) | 13912 | methyl 2-(4-aminophenyl)propanoate | 39718-97-3 | C10H13NO2 | 详情 | 详情 |
(VI) | 12127 | 3-Chloro-2-methyl-1-propene; Isobutenyl chloride | 563-47-3 | C4H7Cl | 详情 | 详情 |
(VII) | 30309 | methyl 2-[4-[(2-methyl-2-propenyl)amino]phenyl]propanoate | C14H19NO2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VI)6-O-Methylerythromycin A (I) was converted to a mixture of (E)- and (Z)-oximes upon treatment with hydroxylamine in refluxing MeOH. Beckmann rearrangement of the required (Z)-isomer (II) in the presence of tosyl chloride and NaHCO3 led to the macrocyclic lactam (III). Smooth acidic hydrolysis of (III) selectively removed the 3-cladinose moiety. The 3-decladinosyl derivative (IV) was then protected as the 2' acetate (V) employing Ac2O in the presence of NaHCO3. Subsequent acylation of the 3-hydroxyl group of (V) with the mixed anhydride prepared from 4-nitrophenylacetic acid (VI) and pivaloyl chloride furnished ester (VII). Finally, methanolysis of the acetate ester group of (VII) provided the title compound.
【1】 Alihodzic, S.; et al.; Synthesis and antibacterial activity of isomeric 15-membered azalides. 40th Intersci Conf Antimicrob Agents Chemother (Sept 17 2000, Toronto) 2001, Abst 1177. |
【2】 Kobrehel, G.; Lazarevski, G.; Kelneric, Z. (Pliva dd); 15-Membered lactams ketolides with antibacterial activity. EP 1070077; JP 2002510701; US 6110965; WO 9951616 . |
【3】 Kobrehel, G.; Lazarevski, G.; Alihodzic, S.; Mutak, S. (Pliva dd); Novel 8a- and 9a-15-membered lactams. EP 1181298; WO 0063223 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 18631 | (3R,4S,5R,6R,7R,9R,11R,12R,13S,14R)-6-[[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-14-ethyl-12,13-dihydroxy-4-[[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy]-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-oxacyclotetradecanedione | C38H69NO13 | 详情 | 详情 | |
(II) | 55084 | (3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-oxacyclotetradecanedione 10-oxime | C38H70N2O13 | 详情 | 详情 | |
(III) | 55085 | (2R,3S,4R,5R,8R,10R,11R,12R,13S,14R)-11-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-2-ethyl-3,4-dihydroxy-13-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-10-methoxy-3,5,8,10,12,14-hexamethyl-1-oxa-7-azacyclopentadecane-6,15-dione | C38H70N2O13 | 详情 | 详情 | |
(IV) | 55086 | (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-2-ethyl-3,4,13-trihydroxy-10-methoxy-3,5,8,10,12,14-hexamethyl-1-oxa-7-azacyclopentadecane-6,15-dione | C30H56N2O10 | 详情 | 详情 | |
(V) | 55087 | (3R,4S,6R)-4-(dimethylamino)-2-{[(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,13-trihydroxy-10-methoxy-3,5,8,10,12,14-hexamethyl-6,15-dioxo-1-oxa-7-azacyclopentadecan-11-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl acetate | C32H58N2O11 | 详情 | 详情 | |
(VI) | 30305 | 2-(4-nitrophenyl)acetic acid | 104-03-0 | C8H7NO4 | 详情 | 详情 |
(VII) | 55089 | (2R,3S,4R,5R,8R,10R,11R,12R,13S,14R)-11-{[(3R,4S,6R)-3-(acetyloxy)-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-2-ethyl-3,4-dihydroxy-10-methoxy-3,5,8,10,12,14-hexamethyl-6,15-dioxo-1-oxa-7-azacyclopentadecan-13-yl 2-(4-nitrophenyl)acetate | C40H63N3O14 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(X)Coupling of p-nitrophenylacetic acid (IX) with p-toluenesulfonamide (X) using CDI provided the N-acyl sulfonamide (XI). The nitro group of (XI) was then reduced by catalytic hydrogenation to furnish aniline (XII). Reductive condensation of aniline (XII) with aldehyde (VIII) in the presence of NaBH(OAc)3 gave rise to amine (XIII). Finally, simultaneous removal of the O-silyl and N-Boc protecting groups of (XIII) was accomplished by treatment with 4 N aqueous HCl.
【1】 Uehling, D.E.; Donaldson, K.H.; Deaton, D.N.; Hyman, C.E.; Sugg, E.E.; Barret, D.G.; Hughes, R.G.; Reitter, B.; Adkison, K.K.; Lancaster, M.E.; Lee, F.; Hart, R.; Paulik, M.A.; Sherman, B.W.; True, T.; Cowan, C.; Synthesis and evaluation of potent and selective beta3 adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres. J Med Chem 2002, 45, 3, 567. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VIII) | 59936 | tert-butyl (2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-(3-chlorophenyl)ethyl[(1R)-1-methyl-2-oxoethyl]carbamate | C22H36ClNO4Si | 详情 | 详情 | |
(IX) | 59937 | 4-methylbenzenesulfonamide | 70-55-3 | C7H9NO2S | 详情 | 详情 |
(X) | 30305 | 2-(4-nitrophenyl)acetic acid | 104-03-0 | C8H7NO4 | 详情 | 详情 |
(XI) | 59938 | 4-methyl-N-[2-(4-nitrophenyl)acetyl]benzenesulfonamide | C15H14N2O5S | 详情 | 详情 | |
(XII) | 59939 | N-[2-(4-aminophenyl)acetyl]-4-methylbenzenesulfonamide | C15H16N2O3S | 详情 | 详情 | |
(XIII) | 59940 | tert-butyl (2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-(3-chlorophenyl)ethyl{(1R)-1-methyl-2-[4-(2-{[(4-methylphenyl)sulfonyl]amino}-2-oxoethyl)anilino]ethyl}carbamate | C37H52ClN3O6SSi | 详情 | 详情 |